Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,419 | -3,821 | -1,864 | -7,718 | -6,286 |
| Depreciation Amortization | 122 | 90 | 52 | 199 | 162 |
| Accounts payable and accrued liabilities | 16 | -36 | 374 | -346 | -175 |
| Other Working Capital | 661 | 492 | 626 | -633 | -577 |
| Other Operating Activity | 21 | 37 | -373 | 679 | 506 |
| Operating Cash Flow | $-4,599 | $-3,239 | $-1,185 | $-7,820 | $-6,370 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -307 | -306 |
| Investing Cash Flow | $N/A | $N/A | $0 | $-307 | $-306 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,000 | 2,000 |
| Debt Repayment | -3 | -2 | -1 | -5 | -3 |
| Common Stock Issued | 3,847 | 3,847 | N/A | 10,225 | 12,069 |
| Other Financing Activity | -465 | -465 | 0 | -2,000 | -3,844 |
| Financing Cash Flow | $3,379 | $3,380 | $-1 | $10,220 | $10,222 |
| Beginning Cash Position | 4,302 | 4,302 | 4,302 | 2,209 | 2,209 |
| End Cash Position | 3,082 | 4,443 | 3,116 | 4,302 | 5,756 |
| Net Cash Flow | $-1,220 | $141 | $-1,186 | $2,093 | $3,547 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,599 | -3,239 | -1,185 | -7,820 | -6,370 |
| Capital Expenditure | N/A | N/A | 0 | -307 | -306 |
| Free Cash Flow | -4,599 | -3,239 | -1,185 | -8,127 | -6,675 |